Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.

about

Interferon α Induces the Apoptosis of Cervical Cancer HeLa Cells by Activating both the Intrinsic Mitochondrial Pathway and Endoplasmic Reticulum Stress-Induced Pathway.

P2860

Q37465474-4F55DA92-EF85-4EC7-87AE-3F093D445CAE

P2860

Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q38867820

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Combination with third-generat ...... hed bone renal cell carcinoma.

@en

type

Item

label

Combination with third-generat ...... hed bone renal cell carcinoma.

@en

prefLabel

Combination with third-generat ...... hed bone renal cell carcinoma.

@en

P1476

Combination with third-generat ...... hed bone renal cell carcinoma.

@en

P2093

Atsushi Kurabayashi

http://www.w3.org/2001/XMLSchema#string

Chiaki Kawada

http://www.w3.org/2001/XMLSchema#string

Hideo Fukuhara

http://www.w3.org/2001/XMLSchema#string

Keiji Inoue

http://www.w3.org/2001/XMLSchema#string

Mutsuo Furihata

http://www.w3.org/2001/XMLSchema#string

Satoshi Fukata

http://www.w3.org/2001/XMLSchema#string

Takashi Karashima

http://www.w3.org/2001/XMLSchema#string

Taro Shuin

http://www.w3.org/2001/XMLSchema#string

P2860

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

Bisphosphonates induce apoptosis in human breast cancer cell lines

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment.

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.

Myeloma bone disease.

Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.

Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone.

Translational and post-translational modifications of proteins as a new mechanism of action of alpha-interferon: review article.

P304

1092-1099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12711

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277725221

http://www.w3.org/2001/XMLSchema#string

P698

26041278

http://www.w3.org/2001/XMLSchema#string

P932

4556400

http://www.w3.org/2001/XMLSchema#string

Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.

about

P2860

P2860

Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932